| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |